[go: up one dir, main page]

FR2798291B1 - Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis - Google Patents

Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis

Info

Publication number
FR2798291B1
FR2798291B1 FR9911384A FR9911384A FR2798291B1 FR 2798291 B1 FR2798291 B1 FR 2798291B1 FR 9911384 A FR9911384 A FR 9911384A FR 9911384 A FR9911384 A FR 9911384A FR 2798291 B1 FR2798291 B1 FR 2798291B1
Authority
FR
France
Prior art keywords
acellular compositions
acellular
immunogenic
vaccine
bacillus anthracis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9911384A
Other languages
English (en)
Other versions
FR2798291A1 (fr
Inventor
Michele Mock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9911384A priority Critical patent/FR2798291B1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to PCT/FR2000/002494 priority patent/WO2001019395A1/fr
Priority to GB0411571A priority patent/GB2398242B/en
Priority to US10/069,961 priority patent/US6979449B1/en
Priority to GB0207118A priority patent/GB2370772B/en
Priority to GB0414534A priority patent/GB2400558B/en
Priority to GB0414537A priority patent/GB2400559B/en
Priority to CA2384437A priority patent/CA2384437C/fr
Publication of FR2798291A1 publication Critical patent/FR2798291A1/fr
Priority to HK04108982.9A priority patent/HK1066027B/xx
Application granted granted Critical
Publication of FR2798291B1 publication Critical patent/FR2798291B1/fr
Priority to HK05101310.6A priority patent/HK1068502B/xx
Priority to HK05101248.3A priority patent/HK1068100B/xx
Priority to US11/226,315 priority patent/US7491404B2/en
Priority to US12/341,114 priority patent/US20090110700A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1278—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
FR9911384A 1999-09-10 1999-09-10 Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis Expired - Fee Related FR2798291B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR9911384A FR2798291B1 (fr) 1999-09-10 1999-09-10 Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
CA2384437A CA2384437C (fr) 1999-09-10 2000-09-08 Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
US10/069,961 US6979449B1 (en) 1999-09-10 2000-09-08 Acellular immunogenic compositions and acellular vaccine compositions against Bacillus anthracis
GB0207118A GB2370772B (en) 1999-09-10 2000-09-08 Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis
GB0414534A GB2400558B (en) 1999-09-10 2000-09-08 Passive immunisation against bacillus anthracis
GB0414537A GB2400559B (en) 1999-09-10 2000-09-08 Bacillus anthracis exoantigens
PCT/FR2000/002494 WO2001019395A1 (fr) 1999-09-10 2000-09-08 Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
GB0411571A GB2398242B (en) 1999-09-10 2000-09-08 Bacillus anthracis strain
HK04108982.9A HK1066027B (en) 1999-09-10 2004-11-13 Bacillus anthracis strain
HK05101310.6A HK1068502B (en) 1999-09-10 2005-02-16 Passive immunisation against bacillus anthracis
HK05101248.3A HK1068100B (en) 1999-09-10 2005-02-16 Bacillus anthracis exoantigens
US11/226,315 US7491404B2 (en) 1999-09-10 2005-09-15 Acellular immunogenic compositions and acellular vaccine compositions against Bacillus anthracis
US12/341,114 US20090110700A1 (en) 1999-09-10 2008-12-22 Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9911384A FR2798291B1 (fr) 1999-09-10 1999-09-10 Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis

Publications (2)

Publication Number Publication Date
FR2798291A1 FR2798291A1 (fr) 2001-03-16
FR2798291B1 true FR2798291B1 (fr) 2005-01-14

Family

ID=9549750

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9911384A Expired - Fee Related FR2798291B1 (fr) 1999-09-10 1999-09-10 Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis

Country Status (5)

Country Link
US (3) US6979449B1 (fr)
CA (1) CA2384437C (fr)
FR (1) FR2798291B1 (fr)
GB (1) GB2370772B (fr)
WO (1) WO2001019395A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003048390A1 (fr) * 2001-12-05 2003-06-12 Rakesh Bhatnagar Procede de preparation d'un vaccin non toxique contre l'anthrax
GB0130789D0 (en) 2001-12-21 2002-02-06 King S College London Application of spores
US20030118591A1 (en) * 2001-12-21 2003-06-26 Joshua Levy Passive hyperimmune antibody therapy in the treatment of anthrax
KR100701811B1 (ko) * 2002-05-29 2007-04-02 머크 앤드 캄파니 인코포레이티드 탄저병의 치료 및 치사 인자의 억제에 유용한 화합물
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
US7601351B1 (en) 2002-06-26 2009-10-13 Human Genome Sciences, Inc. Antibodies against protective antigen
JP2006517913A (ja) * 2003-02-13 2006-08-03 ベクトン・ディキンソン・アンド・カンパニー 改良型炭疽ワクチンおよび送達方法
US8409590B2 (en) * 2004-02-11 2013-04-02 Ligocyte Pharmaceuticals, Inc. Anthrax antigens and methods of use
JP2007537256A (ja) * 2004-05-11 2007-12-20 メルク　エンド　カムパニー　インコーポレーテッド Ｎ−スルホン化アミノ酸誘導体調製のためのプロセス
WO2006044728A2 (fr) * 2004-10-18 2006-04-27 U.S.Genomics, Inc. Procedes d'isolation d'acides nucleiques de spores procaryotiques
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
EP1954307A4 (fr) * 2005-11-14 2009-12-02 Univ Maryland Biotech Inst Vaccins oraux a base de salmonelle contre l'anthrax
EP2021021A2 (fr) 2006-05-12 2009-02-11 Oklahoma Medical Research Foundation Compositions contre l'anthrax et procédés d'utilisation et de production de celles-ci
GB0916570D0 (en) * 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method
CN106442039B (zh) 2011-06-19 2020-08-07 阿博根公司 用于样品采集的装置、溶液和方法
CA2950419C (fr) * 2014-05-27 2023-04-25 Dna Genotek Inc. Composition et procede de stabilisation et de maintien de la viabilite de micro-organismes rustiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676068B1 (fr) * 1991-05-02 1994-11-04 Pasteur Institut Souches recombinantes immunogenes de b. anthracis - compositions immunogenes les contenant.
RU2115433C1 (ru) * 1992-08-28 1998-07-20 Научно-исследовательский институт микробиологии МО РФ Вакцина сибиреязвенная комбинированная
EP0739981A1 (fr) * 1995-04-25 1996-10-30 Vrije Universiteit Brussel Fragments variables d'immunoglobulines-utilisation thérapeutique ou vétérinaire

Also Published As

Publication number Publication date
GB0207118D0 (en) 2002-05-08
WO2001019395A1 (fr) 2001-03-22
US7491404B2 (en) 2009-02-17
HK1068502A1 (en) 2005-04-22
FR2798291A1 (fr) 2001-03-16
CA2384437A1 (fr) 2001-03-22
US20090110700A1 (en) 2009-04-30
GB2370772B (en) 2004-09-01
US20060099228A1 (en) 2006-05-11
US6979449B1 (en) 2005-12-27
CA2384437C (fr) 2012-09-04
HK1068100A1 (en) 2005-04-22
HK1066027A1 (en) 2005-03-11
GB2370772A (en) 2002-07-10

Similar Documents

Publication Publication Date Title
FR2798291B1 (fr) Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
ATE413188T1 (de) Menschliche papillomavirus impfstoff- formulierungen
PL353891A1 (en) Genetically engineered bleb vaccine
AU2001241918A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
HUP0301413A3 (en) Vaccine compositions
ATE321569T1 (de) Kombinierte impfstoffzusammensetzungen
IL151942A0 (en) Compositions and methods for enhancing immunogenicity of antigens
EP1420829A4 (fr) Compositions immunomodulatrices, preparations, et leurs procedes d'utilisation
IL148247A (en) Vaccine and its uses
PL398575A1 (pl) Kompozycja szczepionki przeciwko zakażeniu wirusem Zachodniego Nilu
MA25489A1 (fr) Vaccins
GB9910812D0 (en) Vaccine composition
AU2003270779A8 (en) Vaccine compositions and adjuvant
AU2151902A (en) Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
AU2002221519A1 (en) Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
AU5577201A (en) Immunogenic pneumococcal protein and vaccine compositions thereof
AU2001295672A1 (en) Vaccine composition and stabilisation method
MXPA03002875A (es) Composicion de vacuna y metodo de estabilizacion.
AU2001247453A1 (en) Genetically stable cholera vaccines
GB0411571D0 (en) Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis
AU1101701A (en) Vaccine compositions
GB9911823D0 (en) New vaccine formulations
AU2003281909A1 (en) Method of obtaining conjugate vaccines and vaccine compositions containing same
GB9922561D0 (en) Neisserial vaccine compositions and methods
GB9911825D0 (en) New vaccine formulations

Legal Events

Date Code Title Description
RM Correction of a material error
ST Notification of lapse

Effective date: 20160531